Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease

J Talbot, L Maves - Wiley Interdisciplinary Reviews …, 2016 - Wiley Online Library
Skeletal muscle fibers are classified into fiber types, in particular, slow twitch versus fast
twitch. Muscle fiber types are generally defined by the particular myosin heavy chain …

Function and genetics of dystrophin and dystrophin-related proteins in muscle

DJ Blake, A Weir, SE Newey… - Physiological …, 2002 - journals.physiology.org
The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations
in the gene encoding dystrophin. There is currently no effective treatment for the disease; …

The genetic architecture of adaptations to high altitude in Ethiopia

G Alkorta-Aranburu, CM Beall, DB Witonsky… - PLoS …, 2012 - journals.plos.org
Although hypoxia is a major stress on physiological processes, several human populations
have survived for millennia at high altitudes, suggesting that they have adapted to hypoxic …

Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle

V Ljubicic, P Miura, M Burt, L Boudreault… - Human molecular …, 2011 - academic.oup.com
A therapeutic approach for Duchenne muscular dystrophy (DMD) is to up-regulate utrophin
in skeletal muscle in an effort to compensate for the lack of dystrophin. We previously …

Pharmacological strategies for muscular dystrophy

TS Khurana, KE Davies - Nature Reviews Drug Discovery, 2003 - nature.com
Duchenne muscular dystrophy (DMD) is a fatal, genetic disorder whose relentless
progression underscores the urgency for developing a cure. Although Duchenne initiated …

Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?

P Miura, BJ Jasmin - Trends in molecular medicine, 2006 - cell.com
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder for which there is
currently no effective treatment. This disorder is caused by mutations or deletions in the …

The dystrophin‐glycoprotein complex in the prevention of muscle damage

JD Gumerson, DE Michele - BioMed Research International, 2011 - Wiley Online Library
Muscular dystrophies are genetically diverse but share common phenotypic features of
muscle weakness, degeneration, and progressive decline in muscle function. Previous work …

Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice

JV Chakkalakal, MA Harrison… - Human molecular …, 2004 - academic.oup.com
Utrophin has been studied extensively in recent years in an effort to find a cure for
Duchenne muscular dystrophy. In this context, we previously showed that mice expressing …

Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling

JV Chakkalakal, MA Stocksley… - Proceedings of the …, 2003 - National Acad Sciences
Utrophin levels have recently been shown to be more abundant in slow vs. fast muscles, but
the nature of the molecular events underlying this difference remains to be fully elucidated …

Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis

V Ljubicic, M Burt, JA Lunde… - American Journal of …, 2014 - journals.physiology.org
Slower, more oxidative muscle fibers are more resistant to the dystrophic pathology in
Duchenne muscular dystrophy (DMD) patients as well as in the preclinical mdx mouse …